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To test or not to test: A cross-sectional survey of
the psychosocial determinants of self-testing for
cholesterol, glucose, and HIV
Janaica EJ Grispen1,3, Gaby Ronda1,3*, Geert-Jan Dinant1,3, Nanne K de Vries2,3, Trudy van der Weijden1,3
Abstract
Background: Although self-tests are increasingly available and widely used, it is not clear whether their use is
beneficial to the users, and little is known concerning the determinants of self-test use. The aim of this study was
to identify the determinants of self-test use for cholesterol, glucose, and HIV, and to examine whether these are
similar across these tests. Self-testing was defined as using in-vitro tests on body materials, initiated by consumers
with the aim of diagnosing a particular disorder, condition, or risk factor for disease.
Methods: A cross-sectional Internet survey was conducted among 513 self-testers and 600 non-testers, assessing
possible determinants of self-test use. The structured questionnaire was based on the Health Belief Model, Theory
of Planned Behavior, and Protection Motivation Theory. Data were analyzed by means of logistic regression.
Results: The results revealed that perceived benefits and self-efficacy were significantly associated with self-testing
for all three conditions. Other psychosocial determinants, e.g. gender, cues to action, perceived barriers, subjective
norm, and moral obligation, seemed to be more test-specific.
Conclusions: Psychosocial determinants of self-testing are not identical for all tests and therefore information
about self-testing needs to be tailored to a specific test. The general public should not only be informed about
advantages of self-test use but also about the disadvantages. Designers of information about self-testing should
address all aspects related to self-testing to stimulate informed decision making which, in turn, will result in more
effective self-test use.
Background
A range of self-tests for more than 25 conditions, ran-
ging from infectious diseases to cardiovascular diseases,
has become available to consumers in the Netherlands
and elsewhere [1]. We defined self-tests as in-vitro tests
on body materials such as blood, urine, faeces, or saliva
that are initiated by consumers to diagnose a particular
disorder or risk factor. Four types of self-tests can be
distinguished that are directly available to consumers
without the need to consult a physician first [1]. The
first type comprises the true self-tests, the over-the-
counter tests, in which the consumer is responsible for
execution, interpretation, and follow-up behaviour. The
second type, the so-called street-corner tests, are in
most cases offered by an organization which conducts
the test in local supermarkets, and the results are imme-
diately available. The third and fourth self-test categories
include direct-access laboratory tests and home-collect
or direct-to-consumer tests, in which a consumer
attends a laboratory facility to have body material taken
or sends body material to a laboratory where the test is
done, after which the result is sent to them by mail or
via the Internet.
A 2006 Internet survey of the prevalence of self-test-
ing showed that 16% of a sample of Dutch Internet
users had ever used a self-test, whereas 17% of non-tes-
ters indicated they intended to use a self-test in the
future [1]. Self-testing seems ideal as it fits in with the
right to self-determination. Individuals take responsibil-
ity for their own health by means of self-diagnosis,
which is in line with current views on patient autonomy
and self-management [2,3]. However, the value of self-
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tests has been heavily debated in the scientific literature.
Proponents argue that self-testing increases testing rates,
resulting in more timely diagnosis and treatment, self-
testing is convenient and provides anonymity, and it
promotes patient empowerment [4-7], while opponents
hold that at-risk populations do not use self-tests, self-
tests entail relatively high costs, self-tests can be used
without assessing the whole clinical picture, and testing
without counselling may result in adverse psychological
outcomes [4-6,8]. Additionally, self-testing is one of
many possible tools to diagnose a certain disease or risk
factor and if used outside at-risk populations the possi-
bility of false-positive and false-negative results increases
[2,8]. In other words, it is unclear whether self-tests are
used in a way that is advantageous to the users [5].
Therefore, effective consumer education seems essential
in this new area, as self-tests are likely to become even
more easily available and more widely used [2]. How-
ever, before we can consider educating consumers about
self-testing, it is important to know which factors con-
tribute to the use of self-tests, in order to tailor educa-
tion to these factors. This should result in information
and education stimulating informed decision making
and consequently in more effective use of self-tests [9].
To the best of our knowledge, however, no research to
date has examined the psychosocial determinants of
self-test use. In this study, we made a first attempt to
investigate the psychosocial determinants of self-test
use, specifically for cholesterol, glucose, and HIV tests,
among a sample of Dutch Internet users, and to exam-
ine whether these determinants are similar across the
different tests considered.
This paper focuses on self-tests for cholesterol, glu-
cose and HIV for the following reasons. All three tests
are frequently used in the Netherlands, 38.6%, 34.1%
and 11.1% of all self-testers who indicated having ever
used a self-test performed a cholesterol, glucose, or HIV
self-test, respectively [1]. On the other hand, they differ
in terms of the seriousness of the disorder, varying from
a risk factor to a sexually transmitted (chronic) infection
with serious consequences for the patient’s medical
prognosis and social life. Furthermore, cholesterol and
glucose self-tests are relevant true home self-tests, while
the results of HIV self-tests are usually analysed in a
laboratory [1]. We chose to examine whether the psy-
chosocial determinants of self-testing differ between
those three frequently used, but in several aspects differ-
ent self-tests, because effective consumer information
needs to be tailored to the determinants that are related
to the specific self-test and to the self-test type.
Since little is known about the psychosocial determi-
nants of self-test use a broad spectrum of possible psy-
chosocial determinants was assessed. A questionnaire
was developed, based on the Health Belief Model
(HBM) [10] as well as several concepts of the Theory of
Planned Behaviour (TPB) [11] and the Protection Moti-
vation Theory (PMT) [12]. The HBM was originally
designed to explain relatively simple health behaviours,
such as screening, which may be considered similar to
self-testing [10,13,14]. The HBM states that health-
related behaviour is based on an individual’s perception
of the susceptibility to and the severity of a particular
condition or illness and the individual’s belief that a par-
ticular action would reduce their susceptibility to or the
severity of this condition. However, action will only be
taken if the perceived barriers to the behaviour are out-
weighed by the perceived benefits and if there are cues
(e.g. bodily or environmental events) that trigger action.
In 1988, the self-efficacy concept was added to the
HBM [10,13,15].
Several additional concepts of the TPB and the PMT
were used in this study, such as subjective norm, antici-
pated regret, moral obligation, and response efficacy.
These factors have been shown to contribute to the
explanation of health-related behaviour [16-21]. Table 1
provides an overview of constructs, conceptual defini-
tions, and the items that measured the constructs. The
aim of this study was to identify the determinants of
self-test use and to determine whether these are similar
across different tests.
Methods
Ethical approval
The Medical Ethical Committee of Maastricht Univer-
sity indicated that no ethical approval was needed for
this study.
Participants and procedure
A cross-sectional survey was conducted by a Dutch ISO-
certified institute for online research (ISO 26361 and
20252), named Flycatcher, which was in charge of the
recruitment of participants and the distribution of the
questionnaire. Their Internet panel consists of Dutch-
speaking individuals aged 12 years or older who have an
e-mail address. People can apply for the panel via the
Flycatcher website (http://www.flycatcher.eu). Various
channels are used to recruit new panellists, e.g. mailing
lists of third parties (after permission) and word-of-
mouth advertising. Panellists received an e-mail contain-
ing an invitation to fill out the questionnaire, a link to
the questionnaire, and an expiration date. After one
week, a reminder was sent to panellists who have not
filled out the questionnaire. Based on the length of the
questionnaire, panellists received a certain amount of
credits for filling out the questionnaire. If a certain
amount of credits is earned, panellists can exchange
their credits for an actual incentive (e.g. coupons for
online shops, books, or theatres).
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In the current study, two consecutive questionnaires
were used. Based on the results of this first question-
naire [1], a questionnaire on the psychosocial determi-
nants of a specific self-test was sent to a selection of
self-testers and non-testers. Self-testers received a
questionnaire on the test they had performed (e.g. cho-
lesterol test). If multiple self-tests had been performed, a
hierarchical selection procedure was applied to deter-
mine which test-specific questionnaire was sent, by (1)
selecting all respondents who indicated having
Table 1 Overview of constructs, conceptual definitions, items, and answering options
Constructs and definition
Items/answering optionsa/b
Perceived susceptibility: the individual’s belief of the chance of contracting a certain disease/condition
1. According to you, what are the chances that you will develop elevated cholesterol levels? Answering options: 1 = very low - 5 = very high
2. According to you, what are the chances that you will develop elevated cholesterol levels compared to others of your age and gender? Answering
options: 1 = much smaller - 5 = much larger
Perceived severity: the individual’s belief of the seriousness of a certain disease/condition
1. According to you, how severe is an elevated cholesterol level? Answering options: 1 = not severe at all - 5 = very severe
Cues to action: bodily or environmental events that trigger action such as education, symptoms, media
1. Do you or someone in your immediate environment have elevated cholesterol levels? Answering options: 0 = no, 1 = yes
Perceived benefits: the individual’s belief that a certain action will effectively reduce the disease threat
1. According to me, performing a self-test is important
2. Self-testing means taking responsibility for your own health
3. Self-testing provides a sense of security about your own health
4. An important advantage of this self-test is a fast result
5. An important advantage of this self-test is privacy
6. An important advantage of this self-test is that it saves time
7. By testing myself, I can reassure myself
8. By testing myself I take care of my own health
9. It feels good to take responsibility for my own health
Perceived barriers: the individual’s belief about the negative aspects/costs of a specific health action
1. The costs of this self-test are a barrier to me
2. Testing myself would make me too concerned with my health
3. Being (too) much concerned with my health scares me
4. Just thinking about self-testing scares me
5. Just thinking about self-testing makes me insecure
Self-efficacy: the individual’s confidence in one’s capability to successfully perform a certain action (Recoded: 1 = completely agree - 5 = completely
disagree)
1. Performing this self-test is difficult
2. When performing this self-test I would miss professional assistance
3. When interpreting the test result I would miss professional assistance
Subjective norm: the individual’s belief that a certain individual or group support or reject performing that specific action
1. My partner (or others in my immediate environment) expects me to perform this self-test
Anticipated regret: the individual’s fear of the feeling of regret if a certain action is not performed
1. I would regret it if I didn’t perform this self-test and it subsequently appeared that I have an elevated cholesterol level.
Moral obligation: the individual’s belief of being morally obliged to perform that action
1. I perceive it as a moral obligation to myself to perform this self-test
2. I perceive it as a moral obligation to the people around me to perform this self-test
Response efficacy: the individual’s belief in the effectiveness of a response to control the risk of a certain disease/condition
1. The result of this self-test is reliable
2. If the test result is normal (nothing’s the matter), you can be sure that this result is correct
3. If the test result is abnormal (something’s the matter), you can be sure that this result is correct
4. If the test result indicates that something’s the matter, I’m able to take the correct subsequent action
aExamples are provided for cholesterol testers. For glucose testers the word ‘cholesterol’ is replaced by ‘glucose’. For HIV testers ‘develop elevated cholesterol
levels’ is replaced by ‘become infected with HIV’, ‘how severe is an elevated cholesterol level’ by ‘how severe is HIV, and ‘have elevated cholesterol levels’ by
‘have HIV’.
bUnless stated otherwise, items were measured on a 5-point Likert scale ranging from 1 = completely disagree to 5 = completely agree.
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performed an HIV-test, (2) selecting all respondents
who indicated having performed a glucose test and who
were not included in (1), and (3) selecting all respon-
dents who indicated having performed a cholesterol test
and who were not included in (1) or (2). In addition, a
random sample of non-testers was selected based on
their level of intention to perform a specific self-test.
This resulted in a sample of non-testers equally distribu-
ted over the different tests and the various intention
categories. Figure 1 displays a schematic overview of the
numbers of respondents and non-respondents for each
questionnaire.
Measures
In the current study, two consecutive questionnaires
were used. An initial short questionnaire was sent to
the full Internet-panel, consisting of 12,529 panelists.
This questionnaire was aimed at determining the pre-
valence of the use of self-tests, types of self-tests, and
at providing an overview of demographic
characteristics. The results of the first questionnaire
are reported elsewhere [1].
After two months, a second questionnaire on the psy-
chosocial determinants of a specific self-test was sent to
self-testers and non-testers. Self-testers received a ques-
tionnaire on the test they had performed and non-tes-
ters received a questionnaire on the test they intended
to perform in the future, as indicated in the first ques-
tionnaire (e.g. a cholesterol test). The questionnaire
assessed the possible determinants of self-test use and
was based on the HBM [14], TPB [11], and PMT [12].
The questionnaire measured perceived susceptibility and
severity, cues to action, perceived benefits and barriers,
self-efficacy, subjective norm, anticipated regret, moral
obligation, and response efficacy. All respondents
received a comparable questionnaire, tailored to the test
performed (e.g. cholesterol testers received a question-
naire about the cholesterol test). Perceived susceptibility
was measured with two items which were combined to
form the susceptibility factor (M = 2.61, SD = .91, with
Cholesterol test Glucose test HIV test 
First questionnaire 
No. approached: 12.529 
No. Completed questionnaire:  
7.919 (response rate 63.2%) 
Self-testers 
No. approached: 854 
No. completed questionnaire: 
728 (response rate 85.2%) 
Non-testers 
No. approached: 1.194 
No. completed questionnaire: 
1.077 (response rate 92.7%) 
Self-testers: 
No. approached: 169 
Response rate: 88.8% 
Non-testers: 
No. approached: 200 
Response rate: 91.5% 
Self-testers: 
No. approached: 210 
Response rate: 88.1% 
Non-testers: 
No. approached: 200 
Response rate: 89.5% 
Self-testers: 
No. approached: 134 
Response rate: 79.9% 
Non-testers: 
No. approached: 200 
Response rate: 87.0% 
Second questionnaire 
Figure 1 Flowchart of the questionnaires. This figure depicts the distribution of the participants divided over the questionnaires regarding the
three tests under consideration (cholesterol, glucose, and HIV).
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Cronbach’s a of. 74, .80, and .64 for cholesterol, glucose,
and HIV, respectively). Perceived severity was measured
with one item (M = 4.32, SD = .69), as was cues to action.
Perceived benefits were measured using nine items which
were combined to form the perceived benefits factor (M =
3.49, SD = .52, with Cronbach’s a of .77, .79, and .78 for
cholesterol, glucose, and HIV, respectively), whereas per-
ceived barriers were measured with five items which were
combined to form the perceived barriers factor (M = 2.48,
SD = .67, with Cronbach’s a of .72, .76, and .74 for choles-
terol, glucose, and HIV, respectively). Self-efficacy was
measured with three items which were combined to form
the self-efficacy factor (M = 3.04, SD = .84, with Cron-
bach’s a of .63, .76, and .63 for cholesterol, glucose, and
HIV, respectively). Subjective norm (M = 2.18, SD = .96)
and anticipated regret (M = 3.41, SD = 1.09) were each
assessed with one item. Moral obligation was measured
using two items which were combined to form the moral
obligation factor (M = 2.84, SD = .98, with Cronbach’s a
of .87, .85, and .90 for cholesterol, glucose, and HIV,
respectively). Response efficacy was measured with four
items which were combined to form the response efficacy
factor (M = 3.70, SD = .69, with Cronbach’s a of .81, .78,
and .82 for cholesterol, glucose, and HIV, respectively).
Table 1 provides an overview of constructs, conceptual
definitions, items, and answering options.
Statistical analysis
Analyses were conducted using SPSS 16.0. All analyses
described below were conducted separately for cholesterol,
glucose, and HIV tests. Unless indicated otherwise, an
alpha of .05 was used for statistical significance. First, basic
descriptive statistics were used to describe the respon-
dents’ socio-demographic characteristics. Multiple logistic
regression analyses were then performed, with being a tes-
ter or a non-tester as the outcome variable (non-testers =
0; testers = 1), and socio-demographic characteristics (age,
gender, and level of education), perceived susceptibility
and severity, cues to action, perceived benefits and bar-
riers, self-efficacy, subjective norm, anticipated regret,
moral obligation, and response efficacy as potential predic-
tors. Additionally, independent samples T-tests were per-
formed at item level for each construct, with being a tester
or a non-tester as the group variable. Because of multiple
testing, Bonferroni correction was applied and an alpha of
.001 was used for statistical significance.
Results
Participant characteristics
The questionnaire was sent to a total of 513 self-testers and
600 non-testers, approximately equally distributed between
cholesterol, glucose, and HIV tests, with a response rate
ranging from 79.9% to 91.5% (Figure 1). Respondents were
between 12 and 94 years of age. Analyses revealed no differ-
ences between types of test used and therefore we decided
to combine all test-types. The remainder of the results sec-
tion will only report on the analyses across test-types.
Table 2 presents socio-demographic characteristics of the
respondents and types of tests performed.
Predictors of self-test use
Cholesterol test
Cholesterol testers were more likely to be female than
male. Cholesterol testing was also significantly
Table 2 Socio-demographic characteristics of respondents
Characteristics Cholesterol Glucose HIV
Testers Non-testers Testers Non-testers Testers Non-testers
N 150 183 185 179 107 174
Age Mean 37.9 41.3 42.0 29.3 (738.3 29.3 (729.3 29.3 (732.1
(SD) (14.6) (13.6) (13.1) (13.5) (7.5) (12.5)
(range) (15-82) (12-94) (15-79) (15-81) (19-61) (15-70)
Gender Male 36.7% 40.4% 27.6% 29.6% 26.2% 37.4%
(N) (55) (74) (51) (738(53) (28) (65)
Female 63.3% 59.6% 72.4% 70.4% 73.8% 62.6%
(N) (95) (109) (134) (126) (79) (109)
Level of educationa Low 13.3% 18.6% 23.2% 17.9% 7.5% 12.6%
Intermediate 42.7% 35.5% 45.4% 33.5% 38.3% 49.4%
High 44.0% 45.9% 31.4% 48.6% 54.2% 37.9%
Type of self-test used Home test 35.0% 33% 6.5%
Street-corner test 51.3% 17.3% 6.5%
Direct-access laboratory test 9.3% 15.1% 64.0%
Home-collect test 1.2% 0.5% 1.9%
Different 3.2% 34.1% 21.1%
aLow = primary and secondary school, Intermediate = intermediate vocational education, high = higher vocational education and university.
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associated with perceived susceptibility, perceived bene-
fits, self-efficacy, and moral obligation. However, choles-
terol testers were more likely to perceive fewer barriers
to self-testing and to have a lower level of response effi-
cacy than non-testers (Table 3).
Glucose test
Glucose testing was significantly associated with cues to
action, perceived benefits, and self-efficacy (Table 3).
HIV test
HIV testing was significantly associated with perceived
susceptibility, cues to action, perceived benefits, self-effi-
cacy, and subjective norm. However, HIV testers were
more likely to have a low level of response efficacy than
non-testers (Table 3).
Differences between testers and non-testers at item level
This section reports all differences between self-testers
and non-testers on items that were significant with an
alpha below .001. Differences between self-testers and
non-testers on items for a test with an alpha below .01
are reported if those differences were significant with an
alpha below .001 for the two other tests. An overview of
all analyses on item level is available as additional file
(see additional file 1: Analyses at item-level).
Perceived susceptibility
Glucose testers (p < .001) perceived the chance that they
will develop an elevated cholesterol level as higher than
non-testers. Cholesterol (p < .001), glucose (p < .001),
and HIV testers (p < .01) were more likely than non-tes-
ters to indicate that they perceived themselves as being
more susceptible to develop elevated cholesterol or glu-
cose levels or to become infected with HIV than others
of their age and gender.
Perceived benefits
Compared with non-testers, self-testers were more likely
to indicate that performing a self-test is important, that
self-testing means taking responsibility for one’s own
health, and that privacy is an important advantage of
self-testing (p < .001 for all three tests). Cholesterol (p <
.001), glucose (p < .01), and HIV testers (p < .001) were
also more likely than non-testers to indicate that self-
testing provides a sense of security about one’s own
health. Time-saving was more likely to be seen as an
advantage of self-testing by cholesterol (p < .001), glu-
cose (p < .001) and HIV testers (p < .01) compared to
non-testers. Compared with non-testers, HIV testers
were more likely to indicate that reassurance is an
important advantage of testing (p < .001).
Perceived barriers
Non-testers were more likely than cholesterol (p < .001),
glucose (p < .01), and HIV testers (p < .001) to indicate
that they perceived the costs of self-tests as a barrier.
Self-efficacy
Compared to non-testers, self-testers were more likely
to disagree with the statements ‘performing this self-test
is difficult’ and ‘when performing this self-test I would
miss professional assistance’ (p < .001 for all three tests),
indicating that self-testers have a higher level of self-effi-
cacy. Glucose testers (p < .001) were more likely than
Table 3 Predictors of self-test use
Variable Cholesterol
testa
Glucose
testb
HIV testc
OR OR OR
[95% CI] [95% CI] [95% CI]
Demographics
Gender 2.4 1.2 1.6
[1.2-4.8]* [0.6-2.8] [0.6-4.0]
Age 1.0 1.0 1.0
[1.0-1.0] [1.0-1.0] [0.9-1.0]
Level of educationd
Low 0.6 1.5 0.9
[0.2-1.7] [0.6-4.2] [0.2-4.2]
Intermediate 1.3 1.3 0.5
[0.7-2.6] [0.6-2.9] [0.2-1.2]
High Reference Reference Reference
Health Belief Model
Perceived
susceptibility
1.7 1.0 2.9
[1.0-2.7]* [0.6-1.5] [1.6-5.5] **
Perceived severity 0.6 0.8 1.0
[0.4-1.0] [0.5-1.3] [0.5-2.1]
Cues to action 0.8 3.3 4.7
[0.4-1.6] [1.3-8.3]* [1.4-15.5]*
Perceived benefits 9.4 22.9 150.0
[3.6-24.5]** [7.8-67.7]** [32.7-688.6]
**
Perceived barriers 0.5 1.0 0.8
[0.3-1.0]* [0.5-2.0] [0.4-1.4]
Self-efficacy 10.2 12.9 10.0
[5.6-18.7]** [7.0-23.8]** [4.6-22.0]**
TPB & PMT
Subjective norm 1.1 1.6 1.8
[0.7-1.8] [0.9-2.9] [1.1-3.1]*
Anticipated regret 0.7 1.1 1.2
[0.5-1.1] [0.7-1.8] [0.7-2.1]
Moral obligation 3.5 1.0 1.0
[1.9-6.5]** [0.5-1.9] [0.5-1.8]
Response efficacy 0.5 0.6 0.2
[0.3-0.9]* [0.3-1.1] [0.1-0.5]**
Nagelkerke R2 0.6 0.7 0.7
Note: 0 = non-tester; 1 = self-tester.
*p < .05; ** p < .001
aCholesterol testers = 150, non-testers = 183
bGlucose testers = 185, non-testers = 179
cHIV testers = 107, non-testers = 174
dLow = primary and secondary school, Intermediate = intermediate vocational
education, high = higher vocational education and university
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non-testers to disagree with the statement ‘When inter-
preting the test result I would miss professional
assistance’.
Subjective norm
Cholesterol testers (p < .001) were more likely than
non-testers to indicate that their partners (or others in
their immediate environment) expect from them that
they do the test.
Anticipated regret
Compared to non-testers, HIV testers (p < .001) were
more likely to indicate that they would regret if they did
not perform the test and it subsequently appeared that
they were HIV-positive.
Moral obligation
Cholesterol (p < .001) and HIV testers (p < .001) were
more likely to perceive a moral obligation (towards one-
self and towards others) to perform the test than non-
testers.
Response efficacy
Cholesterol testers (p < .001) indicated to have more
confidence in the accuracy of an abnormal test result
than non-testers. HIV testers (p < .001) were more likely
to indicate that they had less confidence in their ability
to take a correct subsequent action, in case of an abnor-
mal test result, than non-testers.
Discussion
The value of self-tests has been heavily debated in the
scientific literature. Proponents argue that self-testing
increases testing rates, resulting in more timely diagno-
sis and treatment, self-testing is convenient and provides
anonymity, and it promotes patient empowerment [4-7],
while opponents hold that at-risk populations do not
use self-tests, self-tests entail relatively high costs, and
testing without counselling may result in adverse psy-
chological outcomes [4-6]. To the best of our knowl-
edge, however, no research to date has examined the
psychosocial determinants of self-test use. In this study,
we made a first attempt to investigate the psychosocial
determinants of self-test use, specifically for cholesterol,
glucose, and HIV tests, among a sample of Dutch Inter-
net users, and to examine whether these determinants
are similar across the different tests considered.
As expected, based on our theoretical framework, per-
ceived benefits and self-efficacy are important determi-
nants of cholesterol, glucose, and HIV self-testing.
Testers perceived more benefits from performing a self-
test than did non-testers. Benefits may function as
important beliefs supporting a positive attitude, which is
positively associated with intention and behaviour [11].
Alternatively, in view of our operationalization of per-
ceived benefits, testers may perceive self-tests as an
important tool to take responsibility for their own health
[22]. If responsibility is desired, this may be expressed in
self-testing. Additionally, an important motivation for
self-testing is the belief that self-testing provides reas-
surance. In other words, self-testers use a self-test hop-
ing to confirm that they are in good health or have a
healthy lifestyle [22]. These results are supported by lit-
erature about screening behaviour, which also shows
that an important predictor of attending a screening
program is the motivation to be reassured [22,23].
Similarly, our results on self-efficacy as a predictor of
self-test use are in line with a large body of literature
showing that self-efficacy is an important predictor of
intentions [15,17,18,24] and screening behaviour [25],
which may be considered similar to self-testing in cer-
tain ways. Our results show that testers reported signifi-
cantly higher levels of self-efficacy than non-testers in
all three tests considered.
In addition, the results show that gender, perceived
susceptibility, cues to action, perceived barriers, subjec-
tive norm, moral obligation, and response efficacy may
also play important roles, although we did not observe a
significant contribution of these factors for all three self-
tests.
Whereas gender was a significant predictor of choles-
terol self-testing, it was not associated with glucose or
HIV self-test use. This could be explained by the fact
that 51% of all cholesterol self-tests performed in our
sample were street-corner tests, which are mostly car-
ried out in supermarkets. Women are more likely to
shop for the groceries in the Netherlands and therefore
have easier access to these street-corner tests. Glucose
and HIV tests are not offered as street-corner tests in
the Netherlands.
Perceived susceptibility was a significant predictor of
cholesterol and HIV testing, but not of glucose testing.
However, results at item level indicated that glucose-tes-
ters indeed perceived themselves as being significantly
more susceptible to developing diabetes than non-tes-
ters. To explain this contradiction, we tested for colli-
nearity, mediation and moderation, and for interaction
and suppressor effects. Unfortunately, none of these
could account for the contradictory results. Neverthe-
less, the results at item level suggest that perceived sus-
ceptibility is an important predictor of glucose testing as
well.
Results for response efficacy were not consistent and
contrary to theoretical predictions. Regression analyses
indicated that self-testers had a lower level of response
efficacy than non-testers, indicating that self-testers
would perceive their response to the self-test result as
less effective compared to non-testers, whereas the
majority of the analyses at item level indicated the
opposite for all three tests. A possible explanation for
these contradictory results and the large odds ratio and
confidence interval for perceived benefits for HIV
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testing could be the presence of a suppressor variable,
which suppresses irrelevant variance in other predictors,
thus overestimating the importance of these predictors.
Using the method proposed by Mackinnon and collea-
gues [26], we did indeed identify a significant suppressor
effect for perceived benefits and response efficacy (sup-
pressor effect = 0.73 and 1.09; 95% CI [0.37;1.09] and
95% CI [0.49;1.68], for cholesterol and HIV, respec-
tively). Although respondents seem to value the reliabil-
ity of the test (as evidenced by the main effect of
response efficacy on self-testing behaviour), these are
less important as compared to other benefits of self-test-
ing (as evidenced by the fact that the effect of response
efficacy is suppressed when adding perceived benefits to
the analyses).
An alternative explanation for the unexpected effects
of response efficacy for HIV self-testers might be that
HIV testers realize that a positive test-result (something
is the matter) will not automatically lead to a subse-
quent action that can change their condition (see addi-
tional file 1: Analyses at item-level). In other words, the
consequences of a positive test-result have a larger
impact on the HIV-testers’ response efficacy as com-
pared to the characteristics of the self-test itself.
Study limitations and strengths
The study had some limitations that should be
addressed. First, some items were not optimally opera-
tionalized. For instance, cues to action were measured
as ‘Do you or someone in your immediate environment
have elevated cholesterol levels?’. It could be argued that
this is one of many possible cues to action, and this sin-
gle item does not cover the complete construct of cues
to action.
Second, our survey was a retrospective study and con-
clusions about causality thus need to be drawn with
caution. As a result of the study design we used, it
could be assumed that some of the associations we
found might be the result of reverse causality. However,
the relations we found are consistent with theoretical
predictions provided by the HBM and TPB, which
served as a basis for the present study. Furthermore, our
results were strengthened by the fact that determinants
of self-test use were identified in multiple self-tests and
our regression models explained between 61% and 73%
of the variance in self-test use. However, to gain more
insight into the directionality of the relations between
theoretical concepts, a longitudinal study is required.
Third, the present study may have been subject to a
selection bias due to the fact that we used an Internet
research institute. However, studies on Internet surveys
versus paper-and-pencil surveys suggest that Internet
surveys may yield similar results as traditional paper-
and-pencil surveys [27-29]. Furthermore, the Internet
research institute claims that their panel is representa-
tive for the Dutch Internet population and since most
self-tests are bought via the Internet, we consider the
use of this Internet panel as a representative sample of
Dutch self-testers.
Practical implications and future research
Although the pros and cons of self-testing are currently
not clear, self-testing is an existing phenomenon which
is likely to increase in the future. It is therefore essential
that appropriate consumer information will be devel-
oped which is tailored to the general and test-specific
determinants of a self-test, to provide a solid basis for
informed choices about self-testing.
The current study was a first attempt to identify psy-
chosocial determinants that are associated with self-test
use and we found an indication that these determinants
indeed differ between self-tests. However, more research
is needed to identify determinants for self-test use for
risk-factors, chronic diseases, and infectious diseases
other than cholesterol, glucose, and HIV, to establish if
these determinants are indeed test-specific. Furthermore,
we need to identify the consumer’s information use and
needs concerning self-testing, and we have to gain
insight in their follow-up behaviour by preferably using
qualitative research methods. Currently available consu-
mer information on self-testing needs to be assessed to
determine the gaps between the available information
and the consumer’s needs. Another important issue that
needs to be addressed is the level of activation of consu-
mers who are involved in self-testing. Highly activated
consumers are more engaged in self-management and
are more likely to take the appropriate health actions
[30-32]. Insight into these factors is needed to develop
appropriate consumer information which ideally
includes a decision aid on self-testing to promote
informed choice [33-35]. This decision aid needs to be
aimed at guiding consumers in their decision process to
decide whether they are eligible for the test, and if self-
testing is the best test option. Information needs to be
tailored to the determinants that are related to self-test
use and the consumer’s level of activation. By combining
and integrating these factors in consumer information
on self-testing, consumers are stimulated and guided in
making an informed choice about self-testing.
Conclusions
Despite the limitations of the study, we can conclude
that determinants of self-testing cannot be generalized
to all self-tests. Perceived benefits and self-efficacy were
identified as important determinants of self-testing for
three tests but other determinants were more test-speci-
fic. Although perceived benefits are strongly associated
with self-test use, information about self-testing should
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also include information about possible disadvantages in
order to provide consumers with the opportunity to
make informed choices. Additionally, it is very impor-
tant to inform the general public that self-testing is just
one of many possible tools to diagnose a particular
disorder or risk factor, and to provide them with infor-
mation about the possibility of false-positive and false-
negative results and the potential psychological and
financial consequences of test results.
Additional material
Additional file 1: Analyses at item-level. This table shows the results
on the analyses at item-level for all three tests under consideration. The
table contains the means, standard deviations, test values, degrees of
freedom, and p-values for each item.
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